Form 8.3 - [Abbvie. Inc.]
April 14 2020 - 9:59AM
Dow Jones News
TIDM0QCV TIDM0Y7T
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in AbbVie Inc.
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.01 common stock
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 09(th) April 2020
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 69,457,182 4.70362%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 69,457,182 4.70362%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 2,200 79.86
-------------- ----------------------------- -----------------------
Purchase 121 79.94
-------------- ----------------------------- -----------------------
Purchase 7,900 79.19
-------------- ----------------------------- -----------------------
Purchase 2,249 79.75
-------------- ----------------------------- -----------------------
Purchase 500 79.75
-------------- ----------------------------- -----------------------
Purchase 4,400 79.75
-------------- ----------------------------- -----------------------
Purchase 1,100 79.75
-------------- ----------------------------- -----------------------
Purchase 3,500 79.75
-------------- ----------------------------- -----------------------
Purchase 300 79.75
-------------- ----------------------------- -----------------------
Purchase 600 79.75
-------------- ----------------------------- -----------------------
Purchase 51,688 79.75
-------------- ----------------------------- -----------------------
Purchase 4,292 79.75
-------------- ----------------------------- -----------------------
Purchase 1,856 79.75
-------------- ----------------------------- -----------------------
Purchase 1,440 79.75
-------------- ----------------------------- -----------------------
Purchase 500 79.75
-------------- ----------------------------- -----------------------
Purchase 28,620 79.75
-------------- ----------------------------- -----------------------
Purchase 34,528 79.75
-------------- ----------------------------- -----------------------
Purchase 225 79.75
-------------- ----------------------------- -----------------------
Purchase 1,400 79.76
-------------- ----------------------------- -----------------------
Purchase 249 79.75
-------------- ----------------------------- -----------------------
Purchase 1,068 79.75
-------------- ----------------------------- -----------------------
Purchase 267 79.75
-------------- ----------------------------- -----------------------
Purchase 564 79.75
-------------- ----------------------------- -----------------------
Purchase 571 79.75
-------------- ----------------------------- -----------------------
Sale 600 79.75
-------------- ----------------------------- -----------------------
Sale 1,000 79.75
-------------- ----------------------------- -----------------------
Sale 200 79.72
-------------- ----------------------------- -----------------------
Sale 1,109 78.88
-------------- ----------------------------- -----------------------
Sale 2,249 79.75
-------------- ----------------------------- -----------------------
Sale 500 79.75
-------------- ----------------------------- -----------------------
Sale 1,100 79.75
-------------- ----------------------------- -----------------------
Sale 200 79.75
-------------- ----------------------------- -----------------------
Sale 272,034 79.75
-------------- ----------------------------- -----------------------
Sale 11,286 79.75
-------------- ----------------------------- -----------------------
Sale 970 79.75
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- -----------------
Date of disclosure 10(th) April 2020
------------------------------------------------------- -----------------
Contact name Colin Fernandes
------------------------------------------------------- -----------------
Telephone number 020 33956221
------------------------------------------------------- -----------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- -----------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- -----------------
(END) Dow Jones Newswires
April 14, 2020 09:44 ET (13:44 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Allergan (NYSE:AGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Allergan (NYSE:AGN)
Historical Stock Chart
From Apr 2023 to Apr 2024